Best Gold Stocks To Buy Right Now

Costco (NASDAQ: COST  ) was one of the first stocks I purchased for the Prosocial Portfolio I'm managing for Fool.com. It's one of my very favorites -- a company that sets high standards in an industry that generally keeps their standards pretty low. However, I have failed to add to my position.

That's about to change. Finally, I'm purchasing a little more of this gold-standard stock for the portfolio now, two years after the initial buy, and it's long overdue.

An increasing competitive advantage
Costco's been a real winner since I purchased it for the portfolio in December 2010, and before. The company has been a success both in terms of operations and stock price, even weathering the worst of the recessionary environment.

When I bought shares of Costco for the Prosocial Portfolio, which seeks to include positive environmental, social, and governance (ESG) factors in its design, I may have lost a few people. I got the impression that some people couldn't fathom how Costco could possibly be considered a socially responsible company.

Best Gold Stocks To Buy Right Now: Cornerstone Therapeutics Inc.(CRTX)

Cornerstone Therapeutics Inc., a specialty pharmaceutical company, engages in the acquisition, development, and commercialization of prescription pharmaceutical drugs for the hospital, niche respiratory, and related specialty markets. The company offers CUROSURF, a natural lung surfactant used for the treatment of respiratory distress syndrome in premature infants; and ZYFLO CR and ZYFLO, which are leukotriene synthesis inhibitor drugs used for the prevention and chronic treatment of asthma in adults and children. It also provides anti-infective products, such as FACTIVE, a fluoroquinolone antibiotic used for the treatment of acute bacterial exacerbation of chronic bronchitis (ABECB) and community-acquired pneumonia (CAP) of mild to moderate severity; and SPECTRACEF, a antibiotic used for the treatment of respiratory tract infections, pharyngitis and tonsillitis, uncomplicated skin and skin-structure infections, ABECB, and CAP. In addition, the company?s pipeline products include CRTX 080, a vasopressin receptor 2 antagonist lixivaptan used for the treatment of hyponatremia; CRTX 073, an anti-asthma product candidate used for the treatment of asthma; and CRTX 067, a cough/cold product candidate for the treatment of cough and cold. It serves drug wholesalers, retail drug stores, mass merchandisers, and grocery store pharmacies in the United States. The company was formerly known as Critical Therapeutics, Inc. and changed its name to Cornerstone Therapeutics Inc. as a result of its merger with Cornerstone BioPharma Holdings, Inc. in October 2008. Cornerstone Therapeutics Inc. was founded in 2000 and is headquartered in Cary, North Carolina.

Best Gold Stocks To Buy Right Now: Cenveo Inc (CVO)

Cenveo, Inc. is a diversified printing company in North America. The Company�� portfolio of products includes commercial printing, envelope production, labels manufacturing, packaging and publisher offerings. It operates a global network of printing and manufacturing, fulfillment and distribution facilities, which it refers to as manufacturing facilities, serving a diverse base of over 100,000 customers. The Company operates in two segments: envelopes and labels and commercial printing. In August 1, 2011, it completed the acquisition of Nesbitt Graphics, Inc. (Nesbitt). In February 1, 2011, it acquired the assets of MeadWestvaco Corporation's Envelope Product Group (EPG).

Envelopes and Labels

The Company�� envelopes and labels segment operates 31 manufacturing facilities in North America. During the year ended December 31, 2011, its envelopes and labels segment represented approximately 55% of its net sales. It specializes in the design, manufacturing and printing of direct mail and customized envelopes developed for advertising, billing and remittance; custom labels, and stock envelopes and labels. Its envelopes and labels segment serves customers ranging from fortune 50 companies to middle market and small companies serving niche markets. It offers direct mail products used for customer solicitations and custom envelopes used for billing and remittance by end users, including banks, brokerage firms and insurance and credit card companies.

The Company prints a diverse line of custom labels for a range of industries, including manufacturing, warehousing, packaging, food and beverage, and health and beauty, which it sells through networks within the resale channels. It also produces pressure-sensitive prescription labels for the retail pharmacy chain market. It also provides direct mail and overnight packaging labels, food and beverage labels, and shelf and scale labels for national and regional customer accounts. It produces a line of stock envelopes and la! bels that are sold through independent distributors, contract stationers, national catalogs for the office products market, office products superstores and quick printers.

Commercial Printing

The Company�� commercial printing segment operates 36 manufacturing facilities in the United States, Canada, Latin America and Asia. During 2011, its commercial printing segment represented approximately 45% of its net sales. It provides print, design, content management, fulfillment and distribution offerings, including high-end color printing of a range of premium products for major national and regional customers; general commercial printing products for regional and local customers; STM journals, special interest and trade magazines for not-for-profit organizations, educational institutions and specialty publishers, and specialty packaging and promotional materials for multinational consumer products companies.

The Company�� commercial printing segment primarily caters to the consumer products, pharmaceutical, financial services, publishing, and telecommunications industries, with customers ranging from fortune 50 companies to middle market and small companies operating in niche markets. It provides an array of commercial print offerings to its customers, including electronic prepress, digital asset archiving, direct-to-plate technology, color printing on Web and sheet-fed presses and digital printing. The selection of commercial printing products it produces also includes specialty packaging, full body shrink sleeves, journals and specialized periodicals, annual reports, car brochures, direct mail products, advertising literature, corporate identity materials and brand marketing materials. In its journal and specialty magazine business, it offers solutions, including editing, content processing, content management, electronic peer review, production, distribution and reprint marketing. Its primary customers for the specialty packaging and promotional products are pha! rmaceutic! al, apparel, tobacco, neutraceutical and other multi-national consumer product companies.

Advisors' Opinion:

• [By James K. Glassman]

  Cenveo (symbol: CVO) is a printing company with a $2 share price and a price-earnings ratio, based on estimated 2013 earnings, of just 4. It's the choice of Daniel Abramowitz, with Hillson Financial Management in Rockville, Md. Cenveo has a lot of debt, and the stock is speculative, he notes: "But the downside at these levels is limited, and the upside is pretty substantial."

Best Canadian Companies To Invest In Right Now: Palomar Medical Technologies Inc.(PMTI)

Palomar Medical Technologies, Inc., together with its subsidiaries, designs, manufactures, markets, and sells lasers and other light-based products, and related disposable items and accessories for use in dermatology and cosmetic procedures. It provides a range of products based on proprietary technologies that address various cosmetic issues, including hair removal; body sculpting comprising laser-assisted liposuction; removal of vascular lesions, such as rosacea, spider veins, port wine stains, and hemangiomas; wrinkle reduction; removal of leg veins; removal of benign pigmented lesions, including age and sun spots, freckles, and melasma; tattoo removal; acne treatment; skin resurfacing; treatment of red pigmentation in hypertrophic and keloid scars; treatment of verrucae, skin tags, and seborrheic keratosis; skin tightening through soft tissue coagulation; scars comprising acne scars, stretch marks, and warts; and soft tissue coagulation. The company?s proprietary tech nology products include EsteLux pulsed light system, Palomar MediLux pulsed light system, StarLux 300 and StarLux 500 pulsed light and laser systems, Aspire body sculpting system and SlimLipo handpiece, Artisan Platform facial rejuvenation system, Palomar Icon aesthetic system, Acleara acne clearing system, Adivive fat transfer system, SkinTel melanin reader, Palomar Q-YAG 5 system, and Palo Via skin renewing laser. It offers its products through a network of distributors, cable television shopping, high end department stores, online retailers, physician?s offices, spas, and palovia.com in North America, Europe, the Middle East, Asia/Pacific Rim, South and Central America, Australia, and Japan. Palomar Medical Technologies, Inc. was founded in 1987 and is headquartered in Burlington, Massachusetts.